Skip to main content

MoneyWorks4Me

Marksans Pharma informs about press release

21 Aug 2024 Evaluate
Marksans Pharma has informed that it enclosed press release titled ‘Marksans Pharma Limited’s wholly owned subsidiary Relonchem Limited receives Marketing Authorization for its products’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..